##fileformat=VCFv4.1
##INFO=<ID=CONSEQUENCE,Number=.,Type=String,Description="Mutation consequence predictions annotated by SnpEff (subfields: gene_symbol|gene_affected|gene_strand|transcript_name|transcript_affected|protein_affected|consequence_type|cds_mutation|aa_mutation)">
##INFO=<ID=OCCURRENCE,Number=.,Type=String,Description="Mutation occurrence counts broken down by project (subfields: project_code|affected_donors|tested_donors|frequency)">
##INFO=<ID=affected_donors,Number=1,Type=Integer,Description="Number of donors with the current mutation">
##INFO=<ID=mutation,Number=1,Type=String,Description="Somatic mutation definition">
##INFO=<ID=project_count,Number=1,Type=Integer,Description="Number of projects with the current mutation">
##INFO=<ID=studies,Number=1,Type=Integer,Description="Produced from study.">
##INFO=<ID=tested_donors,Number=1,Type=Integer,Description="Total number of donors with SSM data available">
##comment=ICGC open access Simple Somatic Mutations (SSM) data dump in VCF format
##fileDate=2017-06-07T15:49:26.100-04:00
##geneModel=ENSEMBL75
##reference=GRCh37
##source=ICGC25-10
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
1	1000000	MU88749506	T	.	.	.	CONSEQUENCE=.;OCCURRENCE=NKTL-SG|23|23|1.00000;affected_donors=23;mutation=T>T;project_count=1;studies=.;tested_donors=12198
1	100000022	MU39532371	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=SKCA-BR|1|80|0.01250;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100000049	MU87095619	TA	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MALY-DE|1|241|0.00415;affected_donors=1;mutation=A>-;project_count=1;studies=.;tested_donors=12198
1	100000110	MU82202760	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=LICA-FR|2|249|0.00803;affected_donors=2;mutation=G>A;project_count=1;studies=.;tested_donors=12198
1	100000128	MU85052896	A	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MALY-DE|1|241|0.00415;affected_donors=1;mutation=A>C;project_count=1;studies=.;tested_donors=12198
1	10000015	MU91785757	A	G	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-004|ENST00000488540||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=BOCA-UK|1|130|0.00769;affected_donors=1;mutation=A>G;project_count=1;studies=PCAWG;tested_donors=12198
1	100000181	MU259333	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|253|0.00395;affected_donors=1;mutation=G>A;project_count=1;studies=PCAWG;tested_donors=12198
1	100000340	MU64917116	AGGAATAGGGTGGGTCTGTGGCATTTAATCAGCGG	AGTATAGAGTGTAAAGAGT	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=BRCA-EU|1|569|0.00176;affected_donors=1;mutation=AGGAATAGGGTGGGTCTGTGGCATTTAATCAGCGG>AGTATAGAGTGTAAAGAGT;project_count=1;studies=.;tested_donors=12198
1	100000409	MU1214865	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=LIRI-JP|1|258|0.00388;affected_donors=1;mutation=G>A;project_count=1;studies=PCAWG;tested_donors=12198
1	100000520	MU66254099	T	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=BRCA-EU|1|569|0.00176;affected_donors=1;mutation=T>C;project_count=1;studies=.;tested_donors=12198
1	100000600	MU51657082	A	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>G;project_count=1;studies=PCAWG;tested_donors=12198
1	100000874	MU47372259	A	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>G;project_count=1;studies=.;tested_donors=12198
1	100000913	MU80782614	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PBCA-DE|1|499|0.00200;affected_donors=1;mutation=G>A;project_count=1;studies=.;tested_donors=12198
1	100000914	MU55517265	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;studies=.;tested_donors=12198
1	100000961	MU17650851	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|253|0.00395;affected_donors=1;mutation=G>A;project_count=1;studies=PCAWG;tested_donors=12198
1	10000103	MU43972879	G	A	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-004|ENST00000488540||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;studies=.;tested_donors=12198
1	100001073	MU81257146	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=EOPC-DE|1|202|0.00495;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100001214	MU92662179	T	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=OV-AU|1|93|0.01075;affected_donors=1;mutation=T>A;project_count=1;studies=PCAWG;tested_donors=12198
1	100001284	MU66543626	T	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=BRCA-EU|1|569|0.00176;affected_donors=1;mutation=T>A;project_count=1;studies=.;tested_donors=12198
1	100001398	MU3929060	T	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=RECA-EU|1|95|0.01053;affected_donors=1;mutation=T>C;project_count=1;studies=PCAWG;tested_donors=12198
1	100001471	MU4811959	GCCTAACTTCCTGGC	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PACA-AU|1|391|0.00256;affected_donors=1;mutation=CCTAACTTCCTGGC>-;project_count=1;studies=.;tested_donors=12198
1	100001565	MU43111470	A	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>C;project_count=1;studies=.;tested_donors=12198
1	100001674	MU86487357	T	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|253|0.00395;affected_donors=1;mutation=T>C;project_count=1;studies=.;tested_donors=12198
1	100001683	MU88821797	T	TTT	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=LMS-FR|1|67|0.01493;affected_donors=1;mutation=->TT;project_count=1;studies=.;tested_donors=12198
1	100001683	MU88824120	T	TT	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=LMS-FR|1|67|0.01493;affected_donors=1;mutation=->T;project_count=1;studies=.;tested_donors=12198
1	100001689	MU82501377	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PBCA-DE|1|499|0.00200;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100001783	MU4631949	C	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=LIRI-JP|1|258|0.00388;affected_donors=1;mutation=C>G;project_count=1;studies=PCAWG;tested_donors=12198
1	100001852	MU58887544	A	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>G;project_count=1;studies=.;tested_donors=12198
1	100001932	MU84735250	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PBCA-DE|1|499|0.00200;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100002104	MU32523431	TTGCCTTAAAAAATAATGTATTCAAG	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PRAD-UK|1|215|0.00465;affected_donors=1;mutation=TGCCTTAAAAAATAATGTATTCAAG>-;project_count=1;studies=PCAWG;tested_donors=12198
1	100002151	MU86061000	A	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MALY-DE|1|241|0.00415;affected_donors=1;mutation=A>C;project_count=1;studies=.;tested_donors=12198
1	100002188	MU36319710	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=SKCA-BR|1|80|0.01250;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100002261	MU68005356	G	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ORCA-IN|1|131|0.00763;affected_donors=1;mutation=G>C;project_count=1;studies=PCAWG;tested_donors=12198
1	100002298	MU4811981	C	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PACA-AU|1|391|0.00256;affected_donors=1;mutation=C>A;project_count=1;studies=.;tested_donors=12198
1	100002302	MU11131969	C	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PACA-CA|1|260|0.00385;affected_donors=1;mutation=C>A;project_count=1;studies=.;tested_donors=12198
1	100002362	MU54632962	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;studies=.;tested_donors=12198
1	100002713	MU30830102	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|253|0.00395;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100002752	MU85254888	TA	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|253|0.00395;affected_donors=1;mutation=A>-;project_count=1;studies=.;tested_donors=12198
1	100002893	MU54198231	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100002940	MU67631116	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ORCA-IN|1|131|0.00763;affected_donors=1;mutation=G>A;project_count=1;studies=PCAWG;tested_donors=12198
1	100003025	MU38544509	T	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=SKCA-BR|1|80|0.01250;affected_donors=1;mutation=T>A;project_count=1;studies=.;tested_donors=12198
1	100003076	MU48723131	T	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>C;project_count=1;studies=.;tested_donors=12198
1	10000308	MU59803200	C	T	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-004|ENST00000488540||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=PRAD-UK|1|215|0.00465;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100003086	MU50049571	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100003158	MU27361829	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|253|0.00395;affected_donors=1;mutation=G>A;project_count=1;studies=PCAWG;tested_donors=12198
1	100003330	MU61337377	T	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>C;project_count=1;studies=.;tested_donors=12198
1	100003431	MU81291940	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=LICA-CN|1|315|0.00317;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100003437	MU365324	T	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|253|0.00395;affected_donors=1;mutation=T>G;project_count=1;studies=.;tested_donors=12198
1	100003493	MU38089270	A	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=SKCA-BR|1|80|0.01250;affected_donors=1;mutation=A>C;project_count=1;studies=.;tested_donors=12198
1	100003512	MU88518529	C	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|253|0.00395;affected_donors=1;mutation=C>A;project_count=1;studies=.;tested_donors=12198
1	100003569	MU28939469	GA	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PACA-CA|1|260|0.00385;affected_donors=1;mutation=A>-;project_count=1;studies=PCAWG;tested_donors=12198
1	100003614	MU44245003	T	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>A;project_count=1;studies=.;tested_donors=12198
1	100003615	MU49193738	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;studies=PCAWG;tested_donors=12198
1	100003620	MU41307031	A	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>T;project_count=1;studies=.;tested_donors=12198
1	100003664	MU78268308	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=LIRI-JP|1|258|0.00388;affected_donors=1;mutation=C>T;project_count=1;studies=PCAWG;tested_donors=12198
1	100003665	MU66840669	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=BRCA-EU|1|569|0.00176;affected_donors=1;mutation=G>A;project_count=1;studies=.;tested_donors=12198
1	100003683	MU29846696	A	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PAEN-AU|1|52|0.01923;affected_donors=1;mutation=A>G;project_count=1;studies=PCAWG;tested_donors=12198
1	100003758	MU81291956	T	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=LICA-CN|1|315|0.00317;affected_donors=1;mutation=T>A;project_count=1;studies=.;tested_donors=12198
1	100003823	MU37823168	GT	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|253|0.00395;affected_donors=1;mutation=T>-;project_count=1;studies=PCAWG;tested_donors=12198
1	10000394	MU69443547	C	G	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-004|ENST00000488540||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=MALY-DE|1|241|0.00415;affected_donors=1;mutation=C>G;project_count=1;studies=PCAWG;tested_donors=12198
1	100003945	MU28822249	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100004072	MU54129238	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100004105	MU56882215	T	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>G;project_count=1;studies=.;tested_donors=12198
1	100004146	MU53130823	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;studies=.;tested_donors=12198
1	100004208	MU88834956	T	TTTTTTGT	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=LMS-FR|1|67|0.01493;affected_donors=1;mutation=->TTTTTGT;project_count=1;studies=.;tested_donors=12198
1	100004209	MU51795369	G	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>T;project_count=1;studies=.;tested_donors=12198
1	100004217	MU47376103	C	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>G;project_count=1;studies=.;tested_donors=12198
1	100004291	MU4812008	G	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PACA-AU|1|391|0.00256;affected_donors=1;mutation=G>C;project_count=1;studies=.;tested_donors=12198
1	100004483	MU51081961	TA	AC	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=TA>AC;project_count=1;studies=.;tested_donors=12198
1	100004499	MU1617685	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MALY-DE|1|241|0.00415;affected_donors=1;mutation=C>T;project_count=1;studies=PCAWG;tested_donors=12198
1	100004591	MU75948150	A	AT	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PBCA-DE|1|499|0.00200;affected_donors=1;mutation=->T;project_count=1;studies=PCAWG;tested_donors=12198
1	100004611	MU82225808	G	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=LICA-CN|1|315|0.00317;affected_donors=1;mutation=G>T;project_count=1;studies=.;tested_donors=12198
1	100004681	MU36319723	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|80|0.01250;affected_donors=1;mutation=G>A;project_count=1;studies=.;tested_donors=12198
1	100004738	MU64607288	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|569|0.00176;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100004836	MU93731111	T	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=GACA-CN|1|123|0.00813;affected_donors=1;mutation=T>A;project_count=1;studies=PCAWG;tested_donors=12198
1	100004977	MU87055242	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MALY-DE|1|241|0.00415;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100005040	MU56766088	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100005091	MU29372656	A	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PRAD-UK|1|215|0.00465;affected_donors=1;mutation=A>G;project_count=1;studies=PCAWG;tested_donors=12198
1	100005214	MU86094083	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MALY-DE|1|241|0.00415;affected_donors=1;mutation=C>T;project_count=1;studies=.;tested_donors=12198
1	100005234	MU53612832	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;studies=.;tested_donors=12198
1	100005240	MU46206398	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;studies=PCAWG;tested_donors=12198
1	100005246	MU32319144	G	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PRAD-UK|1|215|0.00465;affected_donors=1;mutation=G>C;project_count=1;studies=.;tested_donors=12198
1	100005301	MU45609969	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;studies=PCAWG;tested_donors=12198
1	100005335	MU88302191	G	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=ESAD-UK|1|253|0.00395;affected_donors=1;mutation=G>C;project_count=1;studies=.;tested_donors=12198
1	100005358	MU68498541	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-FR|1|72|0.01389;affected_donors=1;mutation=G>A;project_count=1;studies=.;tested_donors=12198
1	100005465	MU48073637	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;studies=PCAWG;tested_donors=12198
